BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19576595)

  • 21. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke etiologic subtype may influence the rate of hyperdense middle cerebral artery sign disappearance after intravenous thrombolysis.
    Forlivesi S; Bovi P; Tomelleri G; Micheletti N; Carletti M; Moretto G; Cappellari M
    J Thromb Thrombolysis; 2017 Jan; 43(1):86-90. PubMed ID: 27469539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic capacity of hyperdense middle cerebral artery sign in anterior circulation acute ischaemic stroke patients receiving reperfusion therapy: a systematic review and meta-analysis.
    Shi C; Killingsworth MC; Bhaskar SMM
    Acta Neurol Belg; 2022 Apr; 122(2):423-435. PubMed ID: 34095978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
    Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E
    Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proximal hyperdense middle cerebral artery sign predicts poor response to thrombolysis.
    Li Q; Davis S; Mitchell P; Dowling R; Yan B
    PLoS One; 2014; 9(5):e96123. PubMed ID: 24804962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin.
    Mazya MV; Lees KR; Markus R; Roine RO; Seet RC; Wahlgren N; Ahmed N;
    Ann Neurol; 2013 Aug; 74(2):266-74. PubMed ID: 23744571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator.
    Manelfe C; Larrue V; von Kummer R; Bozzao L; Ringleb P; Bastianello S; Iweins F; Lesaffre E
    Stroke; 1999 Apr; 30(4):769-72. PubMed ID: 10187877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperdense middle cerebral artery sign as the only radiological manifestation of hyperacute ischemic stroke in computed tomography.
    Chrzan R; Gleń A; Urbanik A
    Neurol Neurochir Pol; 2017; 51(1):33-37. PubMed ID: 28341040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II.
    Dzialowski I; Hill MD; Coutts SB; Demchuk AM; Kent DM; Wunderlich O; von Kummer R
    Stroke; 2006 Apr; 37(4):973-8. PubMed ID: 16497977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy.
    Tomsick T; Brott T; Barsan W; Broderick J; Haley EC; Spilker J; Khoury J
    AJNR Am J Neuroradiol; 1996 Jan; 17(1):79-85. PubMed ID: 8770253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperdense middle cerebral artery sign in multidetector computed tomography: definition, occurrence, and reliability analysis.
    Abul-Kasim K; Selariu E; Brizzi M; Petersson J
    Neurol India; 2009; 57(2):143-50. PubMed ID: 19439843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
    Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
    Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of intravenous thrombolysis in acute ischemic stroke with hyperdense middle cerebral artery sign].
    Peng L; Guo Y; Wang Y; Lin YN; Zhang CH; Wang HY; Yu RM; Sun XP
    Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):193-197. PubMed ID: 28162169
    [No Abstract]   [Full Text] [Related]  

  • 38. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
    Liao X; Wang Y; Pan Y; Wang C; Zhao X; Wang DZ; Wang C; Liu L; Wang Y;
    Stroke; 2014 Aug; 45(8):2354-8. PubMed ID: 25013020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recanalization after intravenous thrombolysis: does a recanalization time window exist?
    Wunderlich MT; Goertler M; Postert T; Schmitt E; Seidel G; Gahn G; Samii C; Stolz E; ;
    Neurology; 2007 Apr; 68(17):1364-8. PubMed ID: 17452580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.